Skip to main navigation menu Skip to main content Skip to site footer
##common.pageHeaderLogo.altText##

Original article

Vol. 142 No. 0304 (2012)

Management and outcome of severely elevated blood pressure in primary care

  • Christoph Merlo
  • Klaus Bally
  • Benedict Martina
  • Peter Tschudi
  • Andreas Zeller
DOI
https://doi.org/10.4414/smw.2012.13507
Cite this as:
Swiss Med Wkly. 2012;142:w13507
Published
15.01.2012

Summary

OBJECTIVE: In primary care the management of patients with acute severely elevated blood pressure (BP) is challenging. The aim of the study was to evaluate the initial management and outcome of patients presenting to their general practitioner (GP) with severe high blood pressure.

METHODS: Twenty five general practitioners prospectively identified 164 patients presenting with severely elevated blood pressure (systolic BP >180 mm Hg and/or diastolic BP >110 mm Hg). At baseline, patients were categorised as having a hypertensive emergency, urgency or asymptomatic BP elevation. The therapeutic approach of the GPs was assessed and patient outcome at 12 month follow-up was analysed.

RESULTS: Median age of 164 patents was 71 (range 22 to 97) years, 60 (37%) were male and 107 (65%) had pre-existing hypertension. Mean baseline systolic BP was 198 ± 16 (range 145 to 255) mm Hg, mean baseline diastolic BP was 101 ± 15 (range 60 to 130). In total, 99 (60%) of patients had asymptomatic BP elevation, 50 (31%) had hypertensive urgency, and 15 (9%) had a hypertensive emergency. Only around two thirds (61%) of patients were given immediate blood pressure lowering medication (most frequently calcium antagonists). Ten patients (6%) were immediately admitted to hospital. Systolic and diastolic BP declined significantly (p <0.01) between one and six hours after study inclusion (drop of systolic and diastolic BP, 24 ± 9 and 10 ± 1, respectively) and were significantly lower (p <0.01) at three month follow-up compared to the initial measurement (drop of systolic and diastolic BP, 37 ± 6 and 14 ± 4, respectively). On average systolic BP was still above target values after three months (148 ± 21). During 12 months of follow-up patients with hypertensive emergency, hypertensive urgency, and asymptomatic BP elevation experienced a cardiovascular event in 27% vs. 6% vs. 16%, of cases respectively (p = 0.17).

CONCLUSION: The majority of 164 patients who presented with acutely and severely elevated blood pressure (BP >180 +/or >110 mm Hg) to their GPs was asymptomatic, had pre-existing hypertension and was managed in GP’s office unless a hypertensive emergency was present. At three month follow-up mean systolic BP was still above target values.

References

  1. Wolf-Maier K, Cooper RS, Banegas JR, Giampaoli S, Hense HW, Joffres M, et al. Hypertension prevalence and blood pressure levels in 6 european countries, canada, and the united states. JAMA. 2003;289(18):2363–9.
  2. Cherney D and Straus S. Management of patients with hypertensive urgencies and emergencies: A systematic review of the literature. J Gen Intern Med. 2002;17(12):937–45.
  3. Marik PE, Varon J. Hypertensive crises: challenges and management. Chest. 2007;131(6):1949–62.
  4. Varon J, Marik PE. The diagnosis and management of hypertensive crises. Chest. 2000;118(1):214–27.
  5. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, et al. 2007 guidelines for the management of arterial hypertension: The task force for the management of arterial hypertension of the european society of hypertension (esh) and of the european society of cardiology (esc). J Hypertens. 2007;25(6):1105–87.
  6. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jr. et al. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: The jnc 7 report. JAMA. 2003;289(19):2560–72.
  7. Zampaglione B, Pascale C, Marchisio M and Cavallo-Perin P. Hypertensive urgencies and emergencies. Prevalence and clinical presentation. Hypertension. 1996;27(1):144–7.
  8. von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC and Vandenbroucke JP. The strengthening the reporting of observational studies in epidemiology (strobe) statement: Guidelines for reporting observational studies. J Clin Epidemiol. 2008;61(4):344–9.
  9. Kincaid-Smith P, Mc MJ and Murphy EA. The clinical course and pathology of hypertension with papilloedema (malignant hypertension). Q J Med. 1958;27(105):117–53.
  10. Bechgaard P, Kopp H and Nielsen J. One thousand hypertensive patients followed from 16–22 years. Acta Med Scand Suppl. 1956;312:175–84.
  11. Brizio-Molteni L, Molteni A, Cloutier LC, Rainey S. Incidence of post burn hypertensive crisis in patients admitted to two burn centers and a community hospital in the united states. Scand J Plast Reconstr Surg. 1979;13(1):21–8.
  12. Karras DJ, Kruus LK, Cienki JJ, Wald MM, Chiang WK, Shayne P, et al. Evaluation and treatment of patients with severely elevated blood pressure in academic emergency departments: A multicenter study. Ann Emerg Med. 2006;47(3):230–6.
  13. Steinman MA, Fischer MA, Shlipak MG, Bosworth HB, Oddone EZ, Hoffman BB, et al. Clinician awareness of adherence to hypertension guidelines. Am J Med. 2004;117(10):747–54.
  14. Brenner R, Waeber B, Allemann Y. Medical treatment of hypertension in switzerland. The 2009 swiss hypertension survey (swisshype). Swiss Med Wkly. 2011;141(w13169.
  15. Martin JF, Higashiama E, Garcia E, Luizon MR, Cipullo JP. Hypertensive crisis profile. Prevalence and clinical presentation. Arq Bras Cardiol. 2004;83(2):131–6; 25–30.
  16. Wu PH, Yang CY, Yao ZL, Lin WZ, Wu LW, Chang CC. Relationship of blood pressure control and hospitalization risk to medication adherence among patients with hypertension in taiwan. Am J Hypertens. 2010;23(2):155–60.
  17. Tisdale JE, Huang MB and Borzak S. Risk factors for hypertensive crisis: Importance of out-patient blood pressure control. Fam Pract. 2004;21(4):420–4.
  18. Saguner AM, Dur S, Perrig M, Schiemann U, Stuck AE, Burgi U, et al. Risk factors promoting hypertensive crises: Evidence from a longitudinal study. Am J Hypertens. 2010;23(7):775–80.
  19. Tumlin JA, Dunbar LM, Oparil S, Buckalew V, Ram CV, Mathur V, et al. Fenoldopam, a dopamine agonist, for hypertensive emergency: A multicenter randomized trial. Fenoldopam study group. Acad Emerg Med. 2000;7(6):653–62.
  20. Grossman E, Messerli FH, Grodzicki T and Kowey P. Should a moratorium be placed on sublingual nifedipine capsules given for hypertensive emergencies and pseudoemergencies? JAMA. 1996;276(16):1328–31.

Most read articles by the same author(s)

<< < 1 2